Refinement of heterozygosity loss on chromosome 5p15 in sporadic colorectal cancer

World Journal of Gastroenterology

Volumn 9, Issue 8, 2003, Pages 1713-1718

  Xu, Shi Feng ^a   Peng, Zhi Hai ^a   Li, Da Peng ^a   Qiu, Guo Qiang ^a   Zhang, Fang ^a  

^a SHANGHAI FIRST PEOPLE S HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ADULT; AGED; ARTICLE; CARCINOGENESIS; CHROMOSOME; CHROMOSOME 5; CHROMOSOME 5P15; CHROMOSOME ANALYSIS; CHROMOSOME STRUCTURE; COLORECTAL CANCER; COMPUTER PROGRAM; CONTROLLED STUDY; DNA SEQUENCE; ELECTROPHORESIS; FEMALE; GENE DELETION; GENE IDENTIFICATION; GENE LOCUS; GENE MAPPING; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE MARKER; POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE;

EID: 0042423429     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v9.i8.1713     Document Type: Article

References (35)

1. Zhang ZS, Zhang YL. Progress in research of colorectal cancer in China. Shijie Huaren Xiaohua Zazhi 2001; 9: 489-494
2. Zhang YL, Zhang ZS, Wu BP, Zhou DY. Early diagnosis for colorectal cancer in China. World J Gastroenterol 2002; 8: 21-25
3. Becker N. Epidemiology of colorectal cancer. Radiologe 2003; 43: 98-104
4. Yu JP, Dong WG. Current situation about early diagnosis of cancer of large intestine. Shijie Huaren Xiaohua Zazhi 1999; 7: 553-554
5. Lasko D, Cavenee W, Nordenskjold M. Loss of constitutional heterozygosity in human cancer. Annu Rev Genet 1991; 25: 281-314
6. Cliby W, Ritland S, Hartmann L, Dodson M, Halling KC, Keeney G, Podratz KC, Jenkins RB. Human epithelial ovarian cancer allelotype. Cancer Res 1993; 53: 2393-2398
7. Peng Z, Ling Y, Bai S. Loss of heterozygosity on chromosome 3 in sporadic colorectal carcinoma. Zhonghua Yixue Zazhi 2001; 81: 336-339
8. Vogelstein B, Fearon ER, Kern SE, Hamilton SR, Preisinger AC, Nakamura Y, White R. Allelotype of colorectal carcinomas. Science 1989; 244: 207-211
9. Weber TK, Conroy J, Keitz B, Rodriguez-Bigas M, Petrelli NJ, Stoler DL, Anderson GR, Shows TB, Nowak NJ. Genome-wide allelotyping indicates increased loss of heterozygosity on 9p and 14q in early age of onset colorectal cancer. Cytogenet Cell Genet 1999; 86: 142-147
10. Ashton-Rickardt PG, Dunlop MG, Nakamura Y, Morris RG, Purdie CA, Steel CM, Evans HJ, Bird CC, Wyllie AH. High frequency of APC loss in sporadic colorectal carcinoma due to breaks clustered in 5q21-22. Oncogene 1989; 4: 1169-1174
11. Okamoto M, Sato C, Kohno Y, Mori T, Iwama T, Tonomura A, Miki Y, Utsunomiya J, Nakamura Y, White R. Molecular nature of chromosome 5q loss in colorectal tumors and desmoids from patients with familial adenomatous polyposis. Hum Genet 85: 595-599
12. Iacopetta B, DiGrandi S, Dix B, Haig C, Soong R, House A. Loss of heterozygosity of tumour suppressor gene loci in human colorectal carcinoma. Eur J Cancer 1994; 30A: 664-670
13. Zhang F, Zhou C, Ling Y, Qui G, Bai S, Liu W, He L, Peng Z. Allelic analysis on chromosome 5 in sporadic colorectal cancer patients. Zhonghua Zhongliu Zazhi 2002; 24: 458-460
14. Vasen HF, Mecklin JP, Khan PM, Lynch HT. The international collaborative group on hereditary non-polyposis colorectal cancer (ICG-HNPCC). Dis Colon Rectum 1991; 34: 424-425
15. Vasen HFA, Watson P, Mecklin JP, Lynch HT. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology 1999; 116: 1453-1456
16. http://www.ncbi.nlm.nih.gov/mapview/maps.cgi?org=hum&chr=5
17. Kataoka M, Okabayashi T, Johira H, Nakatani S, Nakashima A, Takeda A, Nishizaki M, Orita K, Tanaka N. Aberration of p53 and DCC in gastric and colorectal cancer. Onco/Rep 2000; 7: 99-103
18. Zhou CZ, Peng ZH, Zhang F, Qiu GQ, He L. Loss of heterozygosity on long arm of chromosome 22 in sporadic colorectal carcinoma. World J Gastroenterol 2002; 8: 668-673
19. Komarova NL, Lengauer C, Vogelstein B, Nowak MA. Dynamics of genetic instability in sporadic and familial colorectal cancer. Cancer Biol Ther 2002; 1: 685-692
20. Dong JT. Chromosomal deletions and tumor suppressor genes in prostate cancer. Cancer Metastasis Rev 2001; 20: 173-193
21. Baker SJ, Fearon ER, Nigro JM, Hamilton SR, Preisinger AC, Jessup JM, Van Tuinen P, Ledbetter DH, Barker DF, Nakamura Y, White R, Vogelstein B. Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science 1989; 244: 217-221
22. Kinzler KW, Nibert MC, Vogelstein B, Bryan TM, Levy DB, Smith KJ, Preisinger AC, Hamiton SR, Hedge P, Markham A, Carlson M, Joslyn G, Groden J. Identification of gene located at chromosome 5q21 that is mutated in colorectal cancers. Science 1991; 251: 1366-1370
23. Vito P, Lacana E, D'Adamio L. Interfering with apoptosis: Ca(2+)-binding protein ALG-2 and Alzheimer's disease gene ALG-3. Science 1996; 271: 521-524
24. Krebs J, Klemenz R. The ALG-2/AIP-complex, a modulator at the interface between cell proliferation and cell death? A hypothesis. Biochim Biophys Acta 2000; 1498: 153-161
25. Jung YS, Kim KS, Kim KD, Lim JS, Kim JW, Kim E. Apoptosis-linked gene 2 binds to the death domain of Fas and dissociates from Fas during Fas-mediated apoptosis in Jurkat cells. Biochem Biophys Res Commun 2001; 288: 420-426
26. Krebs J, Saremaslani P, Caduff R. ALG-2: A Ca2+-binding modulator protein involved in cell proliferation and in cell death. Biochim Biophys Acta 2002; 1600: 68-73
27. Kitaura Y, Satoh H, Takahashi H, Shibata H, Maki M. Both ALG-2 and peflin, penta-EF-hand (PEF) proteins, are stabilized by dimerization through their fifth EF-hand regions. Arch Biochem Biophys 2002; 399: 12-18
28. Artandi SE, Chang S, Lee SL, Alson S, Gottlieb GJ, Chin L, DePinho RA. Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice. Nature 2000; 406: 641-645
29. Poole JC, Andrews LG, Tollefsbol TO. Activity, function, and gene regulation of the catalytic subunit of telomerase (hTERT). Gene 2001; 269: 1-12
30. Lee JW, Choi HS, Gyuris J, Brent R, Moore DD. Two classes of proteins dependent on either the presence or absence of thyroid hormone for interaction with the thyroid hormone receptor. Mol Endocrinol 1995; 9: 243-254
31. Yasugi T, Vidal M, Sakai H, Howley PM, Benson JD. Two classes of human papillomavirus type 16 E1 mutants suggest pleiotropic conformational constraints affecting E1 multimerization, E2 interaction, and interaction with cellular proteins. J Virol 1997; 71: 5942-5951
32. Wang Z, Castano IB, De Las Penas A, Adams C, Christman MF. Pol kappa: A DNA polymerase required for sister chromatid cohesion. Science 2000; 289: 774-779
33. Carson DR, Christman MF. Evidence that replication fork components catalyze establishment of cohesion between sister chromatids. Proc Natl Acad Sci U S A 2001; 98: 8270-8275
34. Wang Z, Casatano IB, Adams C, Vu C, Fitzhugh D, Christman MF. Structure/function analysis of the Saccharomyces cerevisiae Trf4/Pol Sigma DNA polymerase. Genetics 2002; 160: 381-391
35. Granger MP, Wright WE, Shay JW. Telomerase in cancer and aging. Crit Rev Oncol Hematol 2002; 41: 29-40